-
Product Insights
![]()
U Minh Upstream Project , Vietnam
U Minh upstream project is located in South China Sea, Vietnam. The upstream project is owned by Jadestone Energy Inc. It will be operated by Jadestone Energy Inc. The project is currently in the announced stage and is expected to start operations in 2025. U Minh Upstream profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ET-02 in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ET-02 in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) Drug Details: ET-02 is...
-
Product Insights
New![]()
Urine Analysis Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Urine Analysis Pipeline Market Report Overview Urine analysis refers to the analysis of urine to aid in the diagnosis of disease or to detect the presence of a specific substance. The Urine Analysis pipeline market research report provides comprehensive information about the Urine Analysis pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·       Urine Analyzers ·       Urine Analyzer Reagents Key Territories ·       ...
-
Product Insights
New![]()
Padern Solar PV Park
Padern Solar PV Park is a solar PV project located in Lisbon, Portugal. The project is owned by NextEnergy Capital Ltd and is developed by Eiffage Energia S L U. The project is at the permitting stage. Empower your strategies with our Padern Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Product Insights
New![]()
Pottendorf
Pottendorf is an Onshore Wind project located in Lower Austria, Austria. The project is owned by Wien Energie GmbH and was developed by Airkraft Windkraftanlagen Errichtungs u. Betriebs AG; OkoEnergie GmbH; Wien Energie GmbH. The project came online in 2015. Empower your strategies with our Pottendorf report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SH-748 in Follicular Lymphoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.SH-748 in Follicular Lymphoma Drug Details:SH-748 is under development for the treatment of relapsed or refractory...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Patritumab Deruxtecan in Non-Small Cell Lung Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Patritumab Deruxtecan in Non-Small Cell Lung Cancer Drug Details: Patritumab deruxtecan (U-31402) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SH-748 in Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.SH-748 in Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma) Drug Details:SH-748 is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SH-748 in Marginal Zone B-cell Lymphoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.SH-748 in Marginal Zone B-cell Lymphoma Drug Details:SH-748 is under development for the treatment of relapsed...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SH-748 in Nodal Marginal Zone B-Cell Lymphoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.SH-748 in Nodal Marginal Zone B-Cell Lymphoma Drug Details:SH-748 is under development for the treatment of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.